AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets

AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets

Submitted by admin on December 9, 2019 - 9:40am
Source: 
Xconomy
News Tags: 
AstraZeneca
Gatehouse Bio
R&D
Respiratory
Cardiovascular
sRNA
Headline: 
AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets
snippet: 

After joining AstraZeneca’s Boston Bio Hub incubator last year, Gatehouse Bio is now teaming up with the pharma company to identify potential drug targets in respiratory and cardiovascular diseases.

Do Not Allow Advertisers to Use My Personal information